CLINICAL_TRIALS
trial_result
· 2010-08-25
Clinical Trial Update: Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment [Phase 1]
Summary
Phase 1 pharmacokinetic study evaluating efavirenz in HIV-1 infected adults with hepatic impairment to assess dosing considerations.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections, Hepatic Impairment | Phase 1 | Status: COMPLETED | Results posted: 2010-08-25